Literature DB >> 25652894

Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines.

Surya K Mallapragada1, Timothy M Brenza2, JoEllyn M McMillan3, Balaji Narasimhan2, Donald S Sakaguchi4, Anup D Sharma2, Svitlana Zbarska4, Howard E Gendelman5.   

Abstract

Nanoparticulate delivery systems represent an area of particular promise for nanoneuromedicines. They possess significant potential for desperately needed therapies designed to combat a range of disorders associated with aging. As such, the field was selected as the focus for the 2014 meeting of the American Society for Nanomedicine. Regenerative, protective, immune modulatory, anti-microbial and anti-inflammatory products, or imaging agents are readily encapsulated in or conjugated to nanoparticles and as such facilitate the delivery of drug payloads to specific action sites across the blood-brain barrier. Diagnostic imaging serves to precisely monitor disease onset and progression while neural stem cell replacement can regenerate damaged tissue through control of stem cell fates. These, taken together, can improve disease burden and limit systemic toxicities. Such enabling technologies serve to protect the nervous system against a broad range of degenerative, traumatic, metabolic, infectious and immune disorders. From the clinical editor: Nanoneuromedicine is a branch of nanomedicine that specifically looks at the nervous system. In the clinical setting, a fundamental hurdle in nervous system disorders is due to an inherent inability of nerve cells to regenerate after damage. Nanotechnology can offer new approaches to overcome these challenges. This review describes recent developments in nanomedicine delivery systems that would affect stem cell repair and regeneration in the nervous system.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug development; Nanoformulation; Nanoneuromedicine; Nanotechnology; Targeting

Mesh:

Year:  2015        PMID: 25652894      PMCID: PMC4628726          DOI: 10.1016/j.nano.2014.12.013

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  179 in total

Review 1.  Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Authors:  David J Begley
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

Review 2.  Need for a paradigm shift in therapeutic approaches to CNS injury.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2012-04       Impact factor: 4.618

3.  Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular zone of the brain.

Authors:  Tiago Santos; Raquel Ferreira; João Maia; Fabienne Agasse; Sara Xapelli; Luísa Cortes; José Bragança; João O Malva; Lino Ferreira; Liliana Bernardino
Journal:  ACS Nano       Date:  2012-11-29       Impact factor: 15.881

4.  A novel nicotinoprotein aldehyde dehydrogenase involved in polyethylene glycol degradation.

Authors:  T Ohta; A Tani; K Kimbara; F Kawai
Journal:  Appl Microbiol Biotechnol       Date:  2005-10-26       Impact factor: 4.813

5.  Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using "pathogen-like" amphiphilic polyanhydride nanoparticles.

Authors:  Ana V Chavez-Santoscoy; Rajarshi Roychoudhury; Nicola L B Pohl; Michael J Wannemuehler; Balaji Narasimhan; Amanda E Ramer-Tait
Journal:  Biomaterials       Date:  2012-04-01       Impact factor: 12.479

6.  A macrophage-nanozyme delivery system for Parkinson's disease.

Authors:  Elena V Batrakova; Shu Li; Ashley D Reynolds; R Lee Mosley; Tatiana K Bronich; Alexander V Kabanov; Howard E Gendelman
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

7.  Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

Authors:  Jörg Kreuter; Dmitry Shamenkov; Valery Petrov; Peter Ramge; Klaus Cychutek; Claudia Koch-Brandt; Renad Alyautdin
Journal:  J Drug Target       Date:  2002-06       Impact factor: 5.121

Review 8.  Metal-organic frameworks as potential drug carriers.

Authors:  Rachel C Huxford; Joseph Della Rocca; Wenbin Lin
Journal:  Curr Opin Chem Biol       Date:  2010-01-12       Impact factor: 8.822

9.  Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.

Authors:  Svetlana Gelperina; Olga Maksimenko; Alexander Khalansky; Lyudmila Vanchugova; Elena Shipulo; Kenul Abbasova; Rustam Berdiev; Stefanie Wohlfart; Nina Chepurnova; Jörg Kreuter
Journal:  Eur J Pharm Biopharm       Date:  2009-09-13       Impact factor: 5.571

Review 10.  Nanoscale drug delivery systems and the blood-brain barrier.

Authors:  Renad Alyautdin; Igor Khalin; Mohd Ismail Nafeeza; Muhammad Huzaimi Haron; Dmitry Kuznetsov
Journal:  Int J Nanomedicine       Date:  2014-02-07
View more
  7 in total

Review 1.  Nano-enabled delivery of diverse payloads across complex biological barriers.

Authors:  Kathleen A Ross; Timothy M Brenza; Andrea M Binnebose; Yashdeep Phanse; Anumantha G Kanthasamy; Howard E Gendelman; Aliasger K Salem; Lyric C Bartholomay; Bryan H Bellaire; Balaji Narasimhan
Journal:  J Control Release       Date:  2015-08-24       Impact factor: 9.776

Review 2.  Neuropharmacologic Approaches to Restore the Brain's Microenvironment.

Authors:  Weizhe Li; Hsin-I Tong; Santhi Gorantla; Larisa Y Poluektova; Howard E Gendelman; Yuanan Lu
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

3.  Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.

Authors:  Timothy M Brenza; Shivani Ghaisas; Julia E Vela Ramirez; Dilshan Harischandra; Vellareddy Anantharam; Balaraman Kalyanaraman; Anumantha G Kanthasamy; Balaji Narasimhan
Journal:  Nanomedicine       Date:  2016-10-19       Impact factor: 5.307

4.  Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.

Authors:  Timothy M Brenza; Benjamin W Schlichtmann; Biju Bhargavan; Julia E Vela Ramirez; Rainie D Nelson; Matthew G Panthani; JoEllyn M McMillan; Balaraman Kalyanaraman; Howard E Gendelman; Vellareddy Anantharam; Anumantha G Kanthasamy; Surya K Mallapragada; Balaji Narasimhan; Georgette D Kanmogne
Journal:  J Biomed Mater Res A       Date:  2018-10-26       Impact factor: 4.396

5.  Delivery of enteric neural progenitors with 5-HT4 agonist-loaded nanoparticles and thermosensitive hydrogel enhances cell proliferation and differentiation following transplantation in vivo.

Authors:  Ryo Hotta; Lily Cheng; Hannah K Graham; Nandor Nagy; Jaime Belkind-Gerson; George Mattheolabakis; Mansoor M Amiji; Allan M Goldstein
Journal:  Biomaterials       Date:  2016-02-17       Impact factor: 12.479

6.  Green synthesis and characterization of iron-oxide nanoparticles using Moringa oleifera: a potential protocol for use in low and middle income countries.

Authors:  Henry Fenekansi Kiwumulo; Haruna Muwonge; Charles Ibingira; Michael Lubwama; John Baptist Kirabira; Robert Tamale Ssekitoleko
Journal:  BMC Res Notes       Date:  2022-04-25

Review 7.  Disentangling Mitochondria in Alzheimer's Disease.

Authors:  Ashu Johri
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.